Andrew Haddad receives NIH TL1 post-doctoral fellowship
Dr. Andrew Haddad, PharmD ’21 was selected as a recipient of the NIH TL1 post-doctoral clinical and translational science fellowship...
Read More... from Andrew Haddad receives NIH TL1 post-doctoral fellowship

